Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

Layer-by-layer vaginal films for acyclovir controlled release to prevent genital herpes

dc.contributor.authorPacheco Quito, Edisson Mauricio
dc.contributor.authorBedoya Del Olmo, Luis Miguel
dc.contributor.authorRubio, Juan
dc.contributor.authorTamayo, Aitana
dc.contributor.authorRuiz Caro, Roberto
dc.contributor.authorVeiga Ochoa, María Dolores
dc.date.accessioned2023-06-22T11:06:55Z
dc.date.available2023-06-22T11:06:55Z
dc.date.issued2022-09-27
dc.descriptionCRUE-CSIC (Acuerdos Transformativos 2022)
dc.description.abstractGenital herpes is one of the most common sexually transmitted infections worldwide. It mainly affects women, as the rate of sexual transmission from male-to-female is higher than from female-to-male. The application of vaginal antivirals drugs could reduce the prevalence of genital herpes and prevent future infections. Layer-bylayer vaginal films were prepared by the solvent evaporation method using iota-carrageenan, hydroxypropyl methylcellulose and the polymethacrylates Eudragit® RS PO and Eudragit® S100, for the controlled release of acyclovir. The films were characterized by texture analysis and Raman spectroscopy. Swelling, mucoadhesion, and drug release studies were conducted in simulated vaginal fluid. The results show that Layer-by-Layer films exhibited adequate mechanical properties. The structuring of the layer-by-layer films allowed the controlled release of acyclovir and produced a prolonged mucoadhesion residence time of up to 192 h. The films formed in layer 2 by the combination of Eudragit® RS PO and S100 showed a controlled release of acyclovir for eight days, and adequate mechanical properties. These promising formulations for the prevention of genital herpes deserve further evaluation.en
dc.description.departmentDepto. de Farmacia Galénica y Tecnología Alimentaria
dc.description.departmentDepto. de Farmacología, Farmacognosia y Botánica
dc.description.facultyFac. de Farmacia
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Ciencia, Innovación y Universidades (España)/Fondo Europeo de Desarrollo Regional
dc.description.sponsorshipMinisterio de Economía, Comercio y Empresa (España)
dc.description.statuspub
dc.eprint.idhttps://eprints.ucm.es/id/eprint/74921
dc.identifier.doi10.1016/j.ijpharm.2022.122239
dc.identifier.issn0378-5173
dc.identifier.officialurlhttps://doi.org/10.1016/j.ijpharm.2022.122239
dc.identifier.urihttps://hdl.handle.net/20.500.14352/72119
dc.journal.titleInternational Journal of Pharmaceutics
dc.language.isoeng
dc.page.initial122239
dc.publisherElsevier
dc.relation.projectIDMAT2016-76416-R
dc.relation.projectIDMAT2012-34552
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España
dc.rights.accessRightsopen access
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.subject.keywordGenital herpes
dc.subject.keywordAcyclovir controlled release
dc.subject.keywordMarine polymers
dc.subject.keywordLayer-by-layer film
dc.subject.keywordIota-carrageenan
dc.subject.keywordHydroxypropyl methylcellulose
dc.subject.ucmFarmacología (Farmacia)
dc.subject.unesco3209 Farmacología
dc.titleLayer-by-layer vaginal films for acyclovir controlled release to prevent genital herpesen
dc.typejournal article
dc.volume.number627
dspace.entity.typePublication
relation.isAuthorOfPublication486fcb53-8da6-4f53-bd30-dbf8c474ba28
relation.isAuthorOfPublication567bff1a-57d2-4c4f-9c25-f46e2b7d5dd3
relation.isAuthorOfPublication29bd420d-26c9-4026-b32c-14d44ef64b88
relation.isAuthorOfPublication.latestForDiscovery567bff1a-57d2-4c4f-9c25-f46e2b7d5dd3

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1-s2.0-S0378517322007943-main.pdf
Size:
3.97 MB
Format:
Adobe Portable Document Format

Collections